Jushi Holdings (JUSHF) Cash from Financing Activities (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly Cash from Financing Activities came in at $11.1 million in Q1 2026, up 228.4% year-on-year from $3.4 million in Q1 2025, and up 540.69% on a QoQ basis from -$2.5 million in Q4 2025.

Jushi Holdings (JUSHF) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Cash from Financing Activities data on file, last reported at $11.1 million in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 228.4% year-over-year to $11.1 million in Q1 2026; TTM through Mar 2026 was $8.5 million, a 158.31% increase from a year earlier, with the FY2025 full-year figure at $767000.0, up 103.14% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $11.1 million, up from -$2.5 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for JUSHF reached as high as $20.1 million in Q2 2023 and fell as low as -$13.7 million in Q3 2024.
  • Historically, Cash from Financing Activities has averaged $2.1 million across 5 years, with a median of -$262000.0 in 2025.
  • Across the five-year window, Cash from Financing Activities tumbled 4971.21% in 2023 and soared 228.4% in 2026, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$2.1 million in 2022, then sank by 59.51% to -$3.3 million in 2023, then jumped by 56.86% to -$1.4 million in 2024, then plunged by 74.91% to -$2.5 million in 2025, then soared by 540.69% to $11.1 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $11.1 million in Q1 2026, -$2.5 million in Q4 2025, and $166000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn 11.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.12 Mn
Mar 31, 2026 11.12 Mn
Dec 31, 2025 -2.52 Mn
Dec 31, 2025 -2.52 Mn
Sep 30, 2025 166,000.00
Sep 30, 2025 166,000.00
Jun 30, 2025 -262,000.00
Jun 30, 2025 -262,000.00
Mar 31, 2025 3.39 Mn
Mar 31, 2025 3.39 Mn
Dec 31, 2024 -1.44 Mn
Dec 31, 2024 -1.44 Mn
Sep 30, 2024 -13.74 Mn
Sep 30, 2024 -13.74 Mn
Jun 30, 2024 -2.78 Mn
Jun 30, 2024 -2.78 Mn
Mar 31, 2024 -6.49 Mn
Mar 31, 2024 -6.49 Mn
Dec 31, 2023 -3.35 Mn
Dec 31, 2023 -3.35 Mn